Unnamed: 0,title,date,stock,sentiment
1270127.0,20 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-06-10 07:35:00-04:00,TTPH,neutral
1270128.0,"The Daily Biotech Pulse: Keytruda Setback For Merck, Denali Pulls The Plug On Neurological Asset",2020-06-10 07:30:00-04:00,TTPH,positive
1270129.0,71 Stocks Moving In Monday's Mid-Day Session,2020-06-08 12:03:00-04:00,TTPH,neutral
1270130.0,33 Stocks Moving in Monday's Pre-Market Session,2020-06-08 07:15:00-04:00,TTPH,neutral
1270131.0,102 Biggest Movers From Friday,2020-06-08 04:54:00-04:00,TTPH,neutral
1270132.0,Mid-Afternoon Market Update: Dow Jumps Over 900 Points; Tetraphase Pharmaceuticals Shares Spike Higher,2020-06-05 14:32:00-04:00,TTPH,positive
1270133.0,75 Stocks Moving In Friday's Mid-Day Session,2020-06-05 12:18:00-04:00,TTPH,neutral
1270134.0,Mid-Day Market Update: Crude Oil Surges 5%; Slack Shares Plummet,2020-06-05 12:07:00-04:00,TTPH,negative
1270135.0,Price Over Earnings Overview: Tetraphase Pharmaceutical,2020-06-05 10:20:00-04:00,TTPH,neutral
1270136.0,Mid-Morning Market Update: Markets Open Higher; U.S. Unemployment Rate Drops To 13.3%,2020-06-05 10:12:00-04:00,TTPH,negative
1270137.0,Tetraphase Pharmaceuticals shares are trading higher after the company received FDA approval for its Supplemental New Drug Application for new strength of XERAVA for injection.,2020-06-05 09:11:00-04:00,TTPH,positive
1270138.0,40 Stocks Moving in Friday's Pre-Market Session,2020-06-05 07:24:00-04:00,TTPH,neutral
1270139.0,Tetraphase Pharma 8-K Shows FDA Approved Supplemental New Drug Application For New Strength Of XERAVA For Injection As Treatment For Complicated Intra-Abdominal Infections,2020-06-05 06:22:00-04:00,TTPH,positive
1270140.0,UPDATE: Tetraphase Pharmaceutical Shares Up 4% After Resumption Of Trading,2020-06-04 09:54:00-04:00,TTPH,positive
1270141.0,"Tetraphase Pharmaceuticals Shares Resume Trading, Previously Halted On News Pending",2020-06-04 09:51:00-04:00,TTPH,positive
1270142.0,"UPDATE: Melinta To Buy Tetraphase For $1.79/Tetraphase Shares, $2.47/Share Of Of Underlying Warrants",2020-06-04 09:34:00-04:00,TTPH,positive
1270143.0,UPDATE: Melinta To Purchase Tetraphase For $39M In Cash Plus Added $16M In Cash Potentially Payable Under Contingent Value Rights,2020-06-04 09:33:00-04:00,TTPH,positive
1270144.0,Melinta Therapeutics to Acquire Tetraphase Pharmaceuticals,2020-06-04 09:23:00-04:00,TTPH,neutral
1270145.0,Tetraphase Pharma Shares Halted News Pending,2020-06-04 08:55:00-04:00,TTPH,positive
1270146.0,"The Daily Biotech Pulse: Positive Readout For Kezar, AstraZeneca Stitches Oncology Partnership, D-Day For Merck's Triple Combo Antibiotic",2020-06-04 08:13:00-04:00,TTPH,positive
1270147.0,Acelrx Pharmaceuticals  Will Be Paid a Break-up Fee of ~$1.8M,2020-06-03 18:52:00-04:00,TTPH,neutral
1270148.0,AcelRx Pharmaceuticals Announces It Will Not Further Revise Its Offer to Acquire Tetraphase,2020-06-03 18:51:00-04:00,TTPH,neutral
1270149.0,"The Daily Biotech Pulse: FDA Nod For Roche's Combo Therapy In Liver Cancer, Allena Rips Higher, Pfizer To Invest Up To $500M In Biotechs",2020-06-02 07:45:00-04:00,TTPH,negative
1270150.0,20 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2020-06-02 07:32:00-04:00,TTPH,neutral
1270151.0,33 Stocks Moving in Tuesday's Pre-Market Session,2020-06-02 07:04:00-04:00,TTPH,neutral
1270152.0,"UPDATE: Under Amended Melinta Proposal, Melinta Has Offered To Acquire Tetraphase For $39M In Cash Plus $16M In Cash Potentially Payable Under Contingent Value Rights",2020-06-01 16:55:00-04:00,TTPH,positive
1270153.0,"Tetraphase Announces Receipt of Amended Melinta Proposal, Determination of Superior Offer and Notice to AcelRx",2020-06-01 16:54:00-04:00,TTPH,positive
1270154.0,"UPDATE: Tetraphase Announces $37M Valuation, $18.7M In Stock Warrants, In Merger With AcelRx",2020-05-29 08:51:00-04:00,TTPH,neutral
1270155.0,AcelRx Pharmaceuticals Announces Revised Merger Agreement With Tetraphase,2020-05-29 08:35:00-04:00,TTPH,positive
1270156.0,"The Daily Biotech Pulse: PhaseBio To Start Potential Pivotal COVID-19 Trial, Immunomedics CEO Quits, Tetraphase Receives Sweetened Offer",2020-05-28 08:24:00-04:00,TTPH,neutral
1270157.0,"Tetraphase Announces Receipt of Amended Melinta Proposal, Determination of Superior Offer and Notice to AcelRx",2020-05-27 20:58:00-04:00,TTPH,positive
1270158.0,"UPDATE: Tetraphase Shareholders Will Receive For Each Share $0.2434/Share In Cash, 0.7217 Shares Of AcelRx Common Stock, 1 Contingent Value Right",2020-05-27 09:56:00-04:00,TTPH,positive
1270159.0,AcelRx Reports Revised Consideration For Tetraphase Deal: $30M In Stock And Cash Plus Added $14.5M In Contingent Value Rights Payable In Cash,2020-05-27 09:55:00-04:00,TTPH,positive
1270160.0,28 Stocks Moving in Tuesday's Pre-Market Session,2020-05-26 07:18:00-04:00,TTPH,neutral
1270161.0,71 Biggest Movers From Friday,2020-05-26 04:30:00-04:00,TTPH,neutral
1270162.0,46 Stocks Moving In Friday's Mid-Day Session,2020-05-22 12:45:00-04:00,TTPH,neutral
1270163.0,Mid-Day Market Update: LiveRamp Surges Following Q4 Results; Syndax Pharmaceuticals Shares Plummet,2020-05-22 12:39:00-04:00,TTPH,positive
1270164.0,20 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-05-22 07:47:00-04:00,TTPH,neutral
1270165.0,30 Stocks Moving in Friday's Pre-Market Session,2020-05-22 07:18:00-04:00,TTPH,neutral
1270166.0,"The Daily Biotech Pulse: FDA Nod For Aquestive, Tetraphase M&A Plot Thickens, Amarin's Vascepa In COVID Fray",2020-05-22 07:10:00-04:00,TTPH,neutral
1270167.0,20 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-05-18 07:34:00-04:00,TTPH,neutral
1270168.0,20 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-05-15 07:33:00-04:00,TTPH,neutral
1270169.0,UPDATE: Tetraphase Board Determine Melinta Offer Could Reasonably Be Expected To Lead To A Superior Offer As Defined In AcelRx Deal,2020-05-15 06:40:00-04:00,TTPH,positive
1270170.0,Tetraphase Pharma 8-K Shows Co. Received Unsolicited Proposal From Melinta Therapeutics To Buy Co. For $27M In Cash Plus Added $12.5M In Cash Payable Under Contingent Value Rights,2020-05-15 06:40:00-04:00,TTPH,positive
1270171.0,Tetraphase  Says On May 12 Received Revised Proposal From La Jolla Pharmaceutical For $22.3M In Cash Plus Additional $12.5M In Cash Under Contingent Value; Co.'s Board At This Time Continues To Recommend AcelRx Merger Agreement,2020-05-13 06:23:00-04:00,TTPH,positive
1270172.0,96 Biggest Movers From Friday,2020-05-11 05:14:00-04:00,TTPH,neutral
1270173.0,70 Stocks Moving In Friday's Mid-Day Session,2020-05-08 12:43:00-04:00,TTPH,neutral
1270174.0,17 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-05-08 07:50:00-04:00,TTPH,neutral
1270175.0,38 Stocks Moving in Friday's Pre-Market Session,2020-05-08 07:36:00-04:00,TTPH,neutral
1270176.0,84 Biggest Movers From Yesterday,2020-05-08 05:34:00-04:00,TTPH,neutral
1270177.0,"Tetraphase Pharmaceutical Q1 EPS $(1.310) Down From $(0.360) YoY, Sales $1.755M Up From $1.273M YoY",2020-05-07 17:09:00-04:00,TTPH,neutral
1270178.0,Bidding War Sends Tetraphase Shares Soaring,2020-05-07 12:55:00-04:00,TTPH,negative
1270179.0,68 Stocks Moving In Thursday's Mid-Day Session,2020-05-07 12:42:00-04:00,TTPH,neutral
1270180.0,"The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500",2020-05-07 07:41:00-04:00,TTPH,negative
1270181.0,20 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-05-07 07:32:00-04:00,TTPH,neutral
1270182.0,36 Stocks Moving in Thursday's Pre-Market Session,2020-05-07 07:15:00-04:00,TTPH,neutral
1270183.0,"The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection",2020-03-19 07:37:00-04:00,TTPH,neutral
1270184.0,"The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates",2020-03-18 07:36:00-04:00,TTPH,positive
1270185.0,"The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment",2020-03-17 08:48:00-04:00,TTPH,neutral
1270186.0,Gabelli & Co. Downgrades Tetraphase Pharmaceutical to Sell,2020-03-17 06:46:00-04:00,TTPH,neutral
1270187.0,AcelRx Pharmaceuticals To Acquire Tetraphase Pharmaceuticals For 0.6303 AcelRx Shares For Each Share Of Tetraphase,2020-03-16 07:31:00-04:00,TTPH,positive
1270188.0,"The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings",2020-03-13 07:52:00-04:00,TTPH,negative
1270189.0,"The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment",2020-03-11 08:03:00-04:00,TTPH,positive
1270190.0,"The Daily Biotech Pulse: Takeda Jumps Into The COVID-19 Fray, Exact Sciences Buys Cancer Diagnostics Companies",2020-03-04 07:37:00-05:00,TTPH,negative
1270191.0,"The Daily Biotech Pulse: GenMark Diagnostics Ships COVID-19 Test Kits, Karyopharm To Offer Shares, And More",2020-03-03 07:51:00-05:00,TTPH,positive
1270192.0,"The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO",2020-02-28 07:28:00-05:00,TTPH,neutral
1270193.0,Stocks That Hit 52-Week Lows On Thursday,2020-02-27 10:23:00-05:00,TTPH,negative
1270194.0,"The Daily Biotech Pulse: Menlo Flunks Midstage Trial, GW Pharma's Earnings, COVID-19 Updates",2020-02-26 09:36:00-05:00,TTPH,negative
1270195.0,"Benzinga's Top Upgrades, Downgrades For January 24, 2020",2020-01-24 09:57:00-05:00,TTPH,positive
1270196.0,Gabelli & Co. Downgrades Tetraphase Pharmaceutical to Hold,2020-01-24 07:23:00-05:00,TTPH,neutral
1270197.0,52 Biggest Movers From Yesterday,2020-01-24 04:40:00-05:00,TTPH,neutral
1270198.0,Mid-Afternoon Market Update: Crude Oil Down 2.5%; Trans World Entertainment Shares Spike Higher,2020-01-23 14:34:00-05:00,TTPH,positive
1270199.0,36 Stocks Moving In Thursday's Mid-Day Session,2020-01-23 14:05:00-05:00,TTPH,neutral
1270200.0,146 Biotechnology Stocks Moving In Thursday's Session,2020-01-23 12:47:00-05:00,TTPH,neutral
1270201.0,Mid-Day Market Update: Markets Down; Procter & Gamble  Reports Mixed Q2 Results,2020-01-23 11:48:00-05:00,TTPH,neutral
1270202.0,Tetraphase Pharmaceuticals Announces $17.5M Of Financings Priced At-The-Market; Says Proceeds Will Fund Commercialization Of XERAVA,2020-01-23 08:51:00-05:00,TTPH,neutral
1270203.0,15 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-01-23 07:36:00-05:00,TTPH,neutral
1270204.0,12 Biotechnology Stocks Moving In Thursday's Pre-Market Session,2020-01-23 07:35:00-05:00,TTPH,neutral
1270205.0,"The Daily Biotech Pulse: Roche Reports Positive SMA Data Readout, Vir Biotech To Work On Virus Treatment",2020-01-23 07:24:00-05:00,TTPH,positive
1270206.0,70 Biggest Movers From Yesterday,2020-01-23 05:52:00-05:00,TTPH,neutral
1270207.0,26 Biotechnology Stocks Moving In Wednesday's After-Market Session,2020-01-22 23:28:00-05:00,TTPH,neutral
1270208.0,36 Healthcare Stocks Moving In Wednesday's After-Market Session,2020-01-22 23:23:00-05:00,TTPH,neutral
1270209.0,98 Biotechnology Stocks Moving In Wednesday's Session,2020-01-22 13:33:00-05:00,TTPH,neutral
1270210.0,116 Healthcare Stocks Moving In Wednesday's Session,2020-01-22 12:37:00-05:00,TTPH,neutral
1270211.0,46 Stocks Moving In Wednesday's Mid-Day Session,2020-01-22 12:05:00-05:00,TTPH,neutral
1270212.0,76 Biggest Movers From Yesterday,2020-01-17 04:54:00-05:00,TTPH,neutral
1270213.0,55 Biggest Movers From Yesterday,2019-12-31 04:21:00-05:00,TTPH,neutral
1270214.0,32 Stocks Moving In Monday's Mid-Day Session,2019-12-30 12:13:00-05:00,TTPH,neutral
1270215.0,25 Stocks Moving in Monday's Pre-Market Session,2019-12-30 07:47:00-05:00,TTPH,neutral
1270216.0,58 Biggest Movers From Friday,2019-12-30 04:51:00-05:00,TTPH,neutral
1270217.0,Mid-Afternoon Market Update: China Finance Online Falls After Q3 Results; Iterum Therapeutics Shares Gain,2019-12-27 14:18:00-05:00,TTPH,positive
1270218.0,Mid-Day Market Update: Dow Up 70 Points; Pintec Technology Shares Spike Higher,2019-12-27 12:23:00-05:00,TTPH,positive
1270219.0,46 Stocks Moving In Friday's Mid-Day Session,2019-12-27 12:05:00-05:00,TTPH,neutral
1270220.0,Mid-Morning Market Update: Markets Mostly Higher; Flexion Receives FDA Nod For Zilretta Label Expansion,2019-12-27 10:26:00-05:00,TTPH,neutral
1270221.0,60 Biggest Movers From Yesterday,2019-12-27 04:44:00-05:00,TTPH,neutral
1270222.0,34 Stocks Moving In Thursday's Mid-Day Session,2019-12-26 12:11:00-05:00,TTPH,neutral
1270223.0,"The Daily Biotech Pulse: Seattle Genetics' Bladder Cancer Drug Gets FDA Nod, Paratek Wins Contract For Antibiotic",2019-12-19 07:52:00-05:00,TTPH,negative
1270224.0,"The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win",2019-12-12 07:38:00-05:00,TTPH,positive
1270225.0,"The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint",2019-12-11 07:21:00-05:00,TTPH,negative
1270226.0,Stocks That Hit 52-Week Lows On Tuesday,2019-12-10 14:29:00-05:00,TTPH,negative
1270227.0,24 Stocks Moving in Tuesday's Pre-Market Session,2019-11-26 07:55:00-05:00,TTPH,neutral
1270228.0,"The Daily Biotech Pulse: Endo's Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data",2019-11-20 07:25:00-05:00,TTPH,positive
1270229.0,"The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval",2019-11-15 07:08:00-05:00,TTPH,negative
1270230.0,"The Daily Biotech Pulse: Amarin Braces For Vascepa Adcom Verdict, Biotechs On A Fundraising Spree, Zosano Makes Progress With Migraine Drug Filing",2019-11-14 08:07:00-05:00,TTPH,positive
1270231.0,81 Biggest Movers From Yesterday,2019-11-14 05:20:00-05:00,TTPH,neutral
1270232.0,Stocks That Hit 52-Week Lows On Wednesday,2019-11-13 10:50:00-05:00,TTPH,negative
1270233.0,"The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher",2019-11-13 07:10:00-05:00,TTPH,neutral
1270234.0,"Tetraphase Pharmaceutical Q3 EPS $(6) Beats $(6.7) Estimate, Sales $3.34M Miss $3.52M Estimate",2019-11-12 16:03:00-05:00,TTPH,negative
1270235.0,"The Daily Biotech Pulse: Reata, Kadmon Clinical Readouts, Apyx Medical's Earnings Beat",2019-11-12 07:20:00-05:00,TTPH,neutral
1270236.0,"The Week Ahead In Biotech: Adcom Test For Amarin's Fish Oil Pill, Agile Awaits FDA Verdict",2019-11-10 16:08:00-05:00,TTPH,positive
1270237.0,"The Daily Biotech Pulse: FDA Nod For Sanofi, BioCryst's Edema Drug In Japan, Myriad's Q1 Disappointment",2019-11-05 06:53:00-05:00,TTPH,negative
1270238.0,Stocks That Hit 52-Week Lows On Monday,2019-11-04 14:45:00-05:00,TTPH,negative
1270239.0,Tetraphase Pharma Closes $8M Offering: Priced 300K Shares With Pre-Funded Warrants At $3.755/Share,2019-11-01 16:20:00-04:00,TTPH,positive
1270240.0,27 Stocks Moving In Thursday's Mid-Day Session,2019-10-31 11:51:00-04:00,TTPH,neutral
1270241.0,15 Stocks Moving in Thursday's Pre-Market Session,2019-10-31 09:32:00-04:00,TTPH,neutral
1270242.0,"Gabelli & Co. Upgrades Tetraphase Pharmaceutical to Buy, Announces $5 Price Target",2019-10-31 06:42:00-04:00,TTPH,neutral
1270243.0,Hearing Gabelli Upgrades Tetraphase Pharma,2019-10-30 18:13:00-04:00,TTPH,neutral
1270244.0,28 Stocks Moving In Wednesday's Mid-Day Session,2019-10-30 12:10:00-04:00,TTPH,neutral
1270245.0,Tetraphase Pharmaceuticals Announces $8M Registered Direct Offering Priced At-the-Market,2019-10-30 08:08:00-04:00,TTPH,neutral
1270246.0,"The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings",2019-10-30 07:01:00-04:00,TTPH,negative
1270247.0,41 Biggest Movers From Yesterday,2019-10-30 04:15:00-04:00,TTPH,neutral
1270248.0,46 Biggest Movers From Yesterday,2019-10-29 05:39:00-04:00,TTPH,neutral
1270249.0,46 Biggest Movers From Friday,2019-10-21 05:37:00-04:00,TTPH,neutral
1270250.0,63 Biggest Movers From Yesterday,2019-10-16 04:04:00-04:00,TTPH,neutral
1270251.0,40 Stocks Moving In Tuesday's Mid-Day Session,2019-10-15 12:48:00-04:00,TTPH,neutral
1270252.0,25 Stocks Moving in Tuesday's Pre-Market Session,2019-10-15 07:44:00-04:00,TTPH,neutral
1270253.0,Stocks That Hit 52-Week Lows On Wednesday,2019-10-09 12:55:00-04:00,TTPH,negative
1270254.0,"The Daily Biotech Pulse: FDA Approves Clinuvel Drug, Aclaris Files Patent Lawsuit Against Taro, Viela Out-Licenses Autoimmune Disorder Drug",2019-10-09 07:58:00-04:00,TTPH,negative
1270255.0,42 Biggest Movers From Yesterday,2019-10-09 05:05:00-04:00,TTPH,neutral
1270256.0,30 Stocks Moving In Tuesday's Mid-Day Session,2019-10-08 12:30:00-04:00,TTPH,neutral
1270257.0,Stocks That Hit 52-Week Lows On Tuesday,2019-10-08 12:02:00-04:00,TTPH,negative
1270258.0,Stocks That Hit 52-Week Lows On Friday,2019-10-04 14:32:00-04:00,TTPH,negative
1270259.0,"The Daily Biotech Pulse: IPOs, Puma's Breast Cancer Drug Gets Label Expansion, Buyout Offer For Organovo",2019-10-03 07:34:00-04:00,TTPH,negative
1270260.0,46 Biggest Movers From Yesterday,2019-10-03 05:05:00-04:00,TTPH,neutral
1270261.0,31 Stocks Moving In Wednesday's Mid-Day Session,2019-10-02 12:28:00-04:00,TTPH,neutral
1270262.0,25 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-10-02 08:54:00-04:00,TTPH,neutral
1270263.0,52 Biggest Movers From Friday,2019-09-30 03:39:00-04:00,TTPH,neutral
1270264.0,34 Stocks Moving In Friday's Mid-Day Session,2019-09-27 12:11:00-04:00,TTPH,neutral
1270265.0,Tetraphase Pharmaceuticals Shares Resume Trade,2019-09-27 10:22:00-04:00,TTPH,positive
1270266.0,Tetraphase Pharmaceuticals Shares Halted On Circuit Breaker,2019-09-27 10:17:00-04:00,TTPH,positive
1270267.0,"Tetraphase Pharma Reports 1-For-20 Reverse Stock Split Effective Sep. 27, 2019",2019-09-26 07:04:00-04:00,TTPH,positive
1270268.0,Tetraphase Pharmaceuticals To Present XERAVA (Eravacycline) Data At IDWeek 2019,2019-09-25 07:03:00-04:00,TTPH,neutral
1270269.0,"Benzinga's Top Upgrades, Downgrades For September 3, 2019",2019-09-03 09:42:00-04:00,TTPH,positive
1270270.0,H.C. Wainwright Downgrades Tetraphase Pharmaceutical to Neutral,2019-09-03 08:10:00-04:00,TTPH,neutral
1270271.0,"The Daily Biotech Pulse: Nuvectra Explores Strategic Options, J&J To Contend Opioid Ruling, Sesen Bio Gets New CFO",2019-08-27 07:29:00-04:00,TTPH,positive
1270272.0,Stocks That Hit 52-Week Lows On Monday,2019-08-26 10:28:00-04:00,TTPH,negative
1270273.0,"The Daily Biotech Pulse: Mallinkckrodt's Terlipressin, Deciphera Offering, Sellas Reboots On Earnings",2019-08-15 07:45:00-04:00,TTPH,neutral
1270274.0,"The Daily Biotech Pulse: Jazz Goes Shopping, Portola Offering, Novelion Delays Quarterly Results",2019-08-13 07:25:00-04:00,TTPH,neutral
1270275.0,Stocks That Hit 52-Week Lows Of Monday,2019-08-12 11:14:00-04:00,TTPH,negative
1270276.0,90 Biggest Movers From Friday,2019-08-12 05:49:00-04:00,TTPH,neutral
1270277.0,75 Stocks Moving In Friday's Mid-Day Session,2019-08-09 14:06:00-04:00,TTPH,neutral
1270278.0,31 Healthcare Stocks Moving In Today's Pre-Market Session,2019-08-09 09:00:00-04:00,TTPH,neutral
1270279.0,52 Stocks Moving In Friday's Pre-Market Session,2019-08-09 08:30:00-04:00,TTPH,neutral
1270280.0,50 Healthcare Stocks Moving In Thursday's After-Market Session,2019-08-08 21:56:00-04:00,TTPH,neutral
1270281.0,Tetraphase Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q2 EPS and sales results.,2019-08-08 16:17:00-04:00,TTPH,neutral
1270282.0,"Tetraphase Pharmaceutical Q2 EPS $(0.42) Misses $(0.37) Estimate, Sales $1.073M Miss $2.42M Estimate",2019-08-08 16:14:00-04:00,TTPH,negative
1270283.0,42 Healthcare Stocks Moving In Wednesday's After-Market Session,2019-08-07 21:24:00-04:00,TTPH,neutral
1270284.0,"The Daily Biotech Pulse: Setback For Bristol-Myers Squibb, Gemphire Explodes, Lilly's Nasal Low Blood Sugar Drug",2019-07-25 07:21:00-04:00,TTPH,negative
1270285.0,"The Daily Biotech Pulse: Jounce Jumps On Licensing Deal, Regulus Hit With Partial Clinical Hold, Genomic Health Added to S&P SmallCap Index",2019-07-24 07:08:00-04:00,TTPH,neutral
1270286.0,List of Companies Reaching Yearly Lows Tuesday,2019-07-23 14:58:00-04:00,TTPH,neutral
1270287.0,"The Daily Biotech Pulse: Acadia Schizophrenia Drug Fails, Viveve Plummets, Eisai Gets Breakthrough Therapy Designation",2019-07-23 07:26:00-04:00,TTPH,negative
1270288.0,"The Daily Biotech Pulse: Roche's Flu Drug Aces Late-Stage Trial, Acura Outlicenses Pain Medication, Neuronetics Gets New Finance Chief",2019-07-03 07:31:00-04:00,TTPH,negative
1270289.0,"The Daily Biotech Pulse: Verrica Rallies, Aclaris Flunked Hair Loss Study, 3 Biotechs To IPO",2019-06-27 07:26:00-04:00,TTPH,negative
1270290.0,"The Daily Biotech Pulse: Decision Day For Regeneron-Sanofi, Vermillion Offering, PDL BioPharma CFO to Depart",2019-06-26 07:19:00-04:00,TTPH,neutral
1270291.0,"The Daily Biotech Pulse: Genfit NASH Drug In China, Conatus Explores Sale, Gilead Stitches Up Immuno-Oncology Partnership",2019-06-25 07:15:00-04:00,TTPH,neutral
1270292.0,Tetraphase Pharma Highlights New XERAVA Studies,2019-06-24 07:17:00-04:00,TTPH,neutral
1270293.0,"The Daily Biotech Pulse: PhaseBio Pumped Up, Eiger Exults On Breakthrough Therapy Designation, Biohaven Slips On Stock Sale",2019-06-18 07:31:00-04:00,TTPH,neutral
1270294.0,"The Daily Biotech Pulse: Savara Slumps On Flunked Trial, NuCana Takes Off, Tetraphase Downsizes",2019-06-13 07:44:00-04:00,TTPH,negative
1270295.0,Tetraphase Pharma To Present Data At Upcoming American Society for Microbiology Microbe 2019 Annual Meeting,2019-06-13 07:03:00-04:00,TTPH,neutral
1270296.0,"UPDATE: Tetraphase Sees Workforce, R&D Expense Reduction Resulting In Annualized Savings Of ~$8M",2019-06-12 16:02:00-04:00,TTPH,neutral
1270297.0,Tetraphase Pharma Reports Corporate Reorg To Maximize XERAVA Commercial Opportunity,2019-06-12 16:01:00-04:00,TTPH,positive
1270298.0,"The Daily Biotech Pulse: Axovant Doses First Patient In Gene Therapy Trial, Agile Resubmits NDA, ADMA Prices Offering",2019-05-17 08:03:00-04:00,TTPH,neutral
1270299.0,"The Daily Biotech Pulse: Further Delay in Roche's Spark Acquisition, FDA Nod For Regeneron, Solid Biosciences Sinks On Earnings",2019-05-14 07:42:00-04:00,TTPH,positive
1270300.0,"Tetraphase Pharmaceutical Q1 EPS $(0.36) Beats $(0.39) Estimate, Sales $1.273M Down From $1.891M YoY",2019-05-08 16:28:00-04:00,TTPH,neutral
1270301.0,"The Daily Biotech Pulse: Daiichi's Positive Breast Cancer Trial, Supernus Slumps, Axovant Reverse Split",2019-05-08 07:53:00-04:00,TTPH,negative
1270302.0,"The Daily Biotech Pulse: Obseva Reports Positive Endometriosis Drug Trial, Assembly Biosciences Execs Depart, Coherus Settles With Amgen",2019-05-03 07:49:00-04:00,TTPH,positive
1270303.0,Tetraphase Pharma Reports 5 Data Presentations At European Congress of Clinical Microbiology and Infectious Diseases Apr. 13-16,2019-04-08 07:06:00-04:00,TTPH,neutral
1270304.0,Tetraphase Pharma Presented Preclinical Data For TP-2846 At AACR Meeting,2019-04-03 08:00:00-04:00,TTPH,neutral
1270305.0,"Benzinga's Top Upgrades, Downgrades For March 16, 2019",2019-03-18 08:53:00-04:00,TTPH,positive
1270306.0,Gabelli & Co. Downgrades Tetraphase Pharmaceutical to Hold,2019-03-18 08:22:00-04:00,TTPH,neutral
1270307.0,"Tetraphase Pharmaceutical Q4 EPS $(0.40), Inline, Sales $4.283M Beat $2.31M Estimate",2019-03-14 16:26:00-04:00,TTPH,neutral
1270308.0,"The Daily Biotech Pulse: Arsanis Completes X4 Merger, EC Nod For Roche, Axovant Offering",2019-03-14 07:47:00-04:00,TTPH,neutral
1270309.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings, IPOs",2019-03-10 14:32:00-04:00,TTPH,neutral
1270310.0,"The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum",2018-12-20 07:53:00-05:00,TTPH,positive
1270311.0,"The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas",2018-12-19 07:46:00-05:00,TTPH,positive
1270312.0,"The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FibroGen, J&J $5B Buyback Plan",2018-12-18 08:00:00-05:00,TTPH,positive
1270313.0,"Stocks Which Set New 52-Week Low Yesterday Tues., Nov. 27, 2018",2018-11-28 11:54:00-05:00,TTPH,negative
1270314.0,"Stocks Which Set New 52-Week Low Yesterday, Mon., Nov. 26, 2018",2018-11-27 11:26:00-05:00,TTPH,negative
1270315.0,"Stocks Which Set New 52-Week Low Yesterday, Mon., Nov. 19, 2018",2018-11-20 09:12:00-05:00,TTPH,negative
1270316.0,"The Daily Biotech Pulse: FDA Nod For Mallinckrodt's Pain Drug, AbbVie-Neurocrine Report Positive Elagolix Results",2018-11-15 08:10:00-05:00,TTPH,positive
1270317.0,76 Biggest Movers From Yesterday,2018-11-15 04:20:00-05:00,TTPH,neutral
1270318.0,58 Stocks Moving In Wednesday's Mid-Day Session,2018-11-14 12:49:00-05:00,TTPH,neutral
1270319.0,"The Daily Biotech Pulse: SITC Presentations Pick Up Pace, Sandoz' Voluntary Recall",2018-11-09 07:32:00-05:00,TTPH,neutral
1270320.0,Tetraphase Pharma Q3 EPS $(0.37) Misses $(0.36) Estimate,2018-11-08 16:03:00-05:00,TTPH,negative
1270321.0,Tetraphase Pharmaceuticals To Announce Data From Post-Hoc Analysis Of Phase 3 Trials Demonstrating Efficacy Of XERAVA October 20-23,2018-10-23 06:36:00-04:00,TTPH,neutral
1270322.0,20 Stocks Moving In Friday's Pre-Market Session,2018-10-12 08:20:00-04:00,TTPH,neutral
1270323.0,"A Peek Into The Markets: US Stock Futures Gain Ahead Of Citigroup, Wells Fargo Earnings",2018-10-12 07:49:00-04:00,TTPH,positive
1270324.0,"Tetraphase Pharmaceuticals shares are trading higher after the company announced the commercial launch of its Intra-Abdominal Infection treatment, XERAVA, in the US.",2018-10-12 07:40:00-04:00,TTPH,positive
1270325.0,"The Daily Biotech Pulse: FDA Thumbs Down For Trevena, Corium To Go Private, Immune Design Discontinues Cancer Vaccine Program",2018-10-12 07:34:00-04:00,TTPH,negative
1270326.0,"6 Stocks To Watch For October 12, 2018",2018-10-12 04:45:00-04:00,TTPH,neutral
1270327.0,"Tetraphase shares are trading up 13% after the company announced the commercial launch of its Intra-Abdominal Infection treatment, XERAVA, in the US.",2018-10-11 16:53:00-04:00,TTPH,positive
1270328.0,5 Stocks Moving In Thursday's After-Hours Session,2018-10-11 16:46:00-04:00,TTPH,neutral
1270329.0,Tetraphase Pharmaceuticals Announces Commercial Launch Of XERAVA In United States,2018-10-11 16:01:00-04:00,TTPH,positive
1270330.0,Tetraphase Pharmaceuticals shares are up 12.8% premarket after the company announced the presentation of Phase 3 XERAVA data at IDWeek 2018; XERAVA demonstrated efficacy in treating secondary bacteramia in patients.,2018-10-08 08:24:00-04:00,TTPH,positive
1270331.0,32 Stocks Moving In Monday's Pre-Market Session,2018-10-08 08:03:00-04:00,TTPH,neutral
1270332.0,Tetraphase Pharmaceuticals Announces Presentation of 'Positive' Data from Phase 3 Trials of XERAVA and Multiple-Ascending Dose Trial of TP-6076 at IDWeek 2018,2018-10-08 06:33:00-04:00,TTPH,neutral
1270333.0,Tetraphase Pharmaceuticals Announces Adoption Of Commission Decision Granting Marketing Authorization Approval In EU For XERAVA In Treatment Of Complicated Intra-Abdominal Infections,2018-09-20 13:10:00-04:00,TTPH,positive
1270334.0,40 Stocks Moving In Thursday's Mid-Day Session,2018-09-06 12:31:00-04:00,TTPH,neutral
1270335.0,"Benzinga's Top Upgrades, Downgrades For September 6, 2018",2018-09-06 09:06:00-04:00,TTPH,positive
1270336.0,WBB Securities Upgrades Tetraphase Pharmaceutical to Buy,2018-09-06 08:45:00-04:00,TTPH,positive
1270337.0,30 Stocks Moving In Tuesday's Mid-Day Session,2018-08-28 12:20:00-04:00,TTPH,neutral
1270338.0,"The Daily Biotech Pulse: Regulatory Roadblock For Akcea-Ionis, Affimed's Alliance, FDA Nod For Tetraphase's Antibiotic",2018-08-28 08:13:00-04:00,TTPH,neutral
1270339.0,30 Stocks Moving In Tuesday's Pre-Market Session,2018-08-28 08:02:00-04:00,TTPH,neutral
1270340.0,"Tetraphase Pharma Shares Resume Trade, Now Up ~2%",2018-08-27 17:01:00-04:00,TTPH,positive
1270341.0,Tetraphase Shares To Resume Trade at 5pm ET,2018-08-27 16:44:00-04:00,TTPH,positive
1270342.0,UPDATE: Tetraphase Expects Q4 Commercial Launch Of XERAVA,2018-08-27 16:21:00-04:00,TTPH,neutral
1270343.0,Tetraphase Pharmaceuticals Announces FDA Approval Of XERAVA (Eravacycline) For Complicated Intra-Abdominal Infections (cIAI),2018-08-27 16:19:00-04:00,TTPH,positive
1270344.0,"REMINDER: Tetraphase Has PDUFA Date Set For Tomorrow, August 28th For Eravacycline",2018-08-27 15:39:00-04:00,TTPH,neutral
1270345.0,"Tetraphase Shares Halted, News Pending",2018-08-27 15:38:00-04:00,TTPH,positive
1270346.0,"The Week Ahead: Best Buy, Lululemon Look To Extend Retail's Rally",2018-08-27 13:30:00-04:00,TTPH,positive
1270347.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Results",2018-08-26 15:40:00-04:00,TTPH,neutral
1270348.0,"The Daily Biotech Pulse: Zafgen Executive Departs; Adamas, Acceleron Accelerate On Earnings",2018-08-03 07:52:00-04:00,TTPH,neutral
1270349.0,"Tetraphase Pharmaceutical Q2 EPS $(0.18) Beats $(0.37) Estimate, Sales $11.6M Beat $2.19M Estimate",2018-08-02 17:03:00-04:00,TTPH,neutral
1270350.0,Attention Biotech Investors: Mark Your Calendar For These August PDUFA Dates,2018-08-01 07:38:00-04:00,TTPH,neutral
1270351.0,Tetraphase Pharmaceuticals Shares Up 12.3% Premarket After Co. Received Positive CHMP Opinion For Xerava As Treatment For Complicated Intra-Abdominal Infections; European Commission Is Expected To Make Final Approval Decision Within Next Three Months,2018-07-27 08:56:00-04:00,TTPH,positive
1270352.0,Tetraphase Pharmaceuticals Receives Positive CHMP Opinion For Xerava As Treatment For Complicated Intra-Abdominal Infections,2018-07-27 08:33:00-04:00,TTPH,positive
1270353.0,40 Biggest Movers From Yesterday,2018-06-15 04:56:00-04:00,TTPH,neutral
1270354.0,31 Stocks Moving In Thursday's Mid-Day Session,2018-06-14 12:26:00-04:00,TTPH,neutral
1270355.0,23 Stocks Moving In Thursday's Pre-Market Session,2018-06-14 08:00:00-04:00,TTPH,neutral
1270356.0,44 Biggest Movers From Yesterday,2018-06-12 04:49:00-04:00,TTPH,neutral
1270357.0,32 Stocks Moving In Monday's Mid-Day Session,2018-06-11 12:25:00-04:00,TTPH,neutral
1270358.0,21 Stocks Moving In Monday's Pre-Market Session,2018-06-11 08:09:00-04:00,TTPH,neutral
1270359.0,Tetraphase Pharmaceuticals Announces Data From Pooled Analysis Of IGNITE1 And IGNITE4 Phase 3 Trials Evaluating Eravacycline In Complicated Intra-Abdominal Infections At ASM Microbe 2018 Annual Meeting,2018-06-11 06:31:00-04:00,TTPH,neutral
1270360.0,Tetraphase Pharmaceuticals Announces Everest Medicines' Submission of an Investigational New Drug Application for Eravacycline; Will Result In A $2.5M Milestone Payment For Tetraphase,2018-06-04 06:01:00-04:00,TTPH,neutral
1270361.0,31 Biggest Movers From Yesterday,2018-05-08 05:12:00-04:00,TTPH,neutral
1270362.0,"Tetraphase Pharmaceutical Q1 EPS $(0.42) Misses $(0.39) Estimate, Sales $1.891M Miss $3.35M Estimate",2018-05-03 16:41:00-04:00,TTPH,negative
1270363.0,"The Week Ahead In Biotech: PDUFA Dates, IPOs And More",2018-04-20 14:00:00-04:00,TTPH,neutral
1270364.0,Gabelli & Co. Upgrades Tetraphase Pharmaceutical to Buy,2018-03-29 09:15:00-04:00,TTPH,neutral
1270365.0,"Tetraphase Pharma Reports Q4 EPS $(0.46) vs $(0.64) Est., Sale $2.528M vs $2.41M Est.",2018-03-06 16:40:00-05:00,TTPH,neutral
1270366.0,"The Week Ahead In Biotech: Earnings, PDUFA Dates And More",2018-03-02 14:12:00-05:00,TTPH,neutral
1270367.0,Tetraphase Pharmaceuticals Names Larry Edwards COO,2018-03-01 16:02:00-05:00,TTPH,neutral
1270368.0,"Priority Review For Tetraphase's Eravacycline A 'Key Positive,' Analyst Says",2018-02-28 14:48:00-05:00,TTPH,neutral
1270369.0,"Benzinga Pro's Top 10 Most-Searched Tickers Wed. Morning: Square, Lipocine, Macy's, Mallinckrodt, Tetraphase Pharma, Zosano Pharma, Arcadia Biosciences, DelMar Pharma, Akers Biosciences, Acorn",2018-02-28 07:17:00-05:00,TTPH,positive
1270370.0,Tetraphase Pharmaceuticals Announces FDA Acceptance for Filing of its NDA Submission for Eravacycline for the Treatment of Complicated Intra-Abdominal Infections,2018-02-27 08:02:00-05:00,TTPH,positive
1270371.0,38 Biggest Movers From Yesterday,2018-02-27 04:58:00-05:00,TTPH,neutral
1270372.0,"WBB Securities Initiates Coverage On Tetraphase Pharmaceutical with Speculative Buy Rating, Announces $6.00 Price Target",2018-02-23 09:39:00-05:00,TTPH,positive
1270373.0,41 Biggest Movers From Yesterday,2018-02-22 05:13:00-05:00,TTPH,neutral
1270374.0,34 Stocks Moving In Wednesday's Mid-Day Session,2018-02-21 12:34:00-05:00,TTPH,neutral
1270375.0,Benzinga Pro's Stocks To Watch Today,2018-02-21 10:23:00-05:00,TTPH,neutral
1270376.0,25 Stocks Moving In Wednesday's Pre-Market Session,2018-02-21 08:02:00-05:00,TTPH,neutral
1270377.0,Tetraphase Pharma Shares Up 7.2% After Hours Following Announcement of Development Agreement With Everest Medicines,2018-02-20 17:06:00-05:00,TTPH,positive
1270378.0,"Tetraphase Pharmaceuticals Enters into Exclusive Agreement with Everest Medicines for Eravacycline in China, Will Receive $7M Upfront Payment With Add'l Milestone Payemnts",2018-02-20 16:14:00-05:00,TTPH,positive
1270379.0,"The Week Ahead In Biotech: Earnings, PDUFA Dates And More",2018-02-19 10:50:00-05:00,TTPH,neutral
1270380.0,22 Stocks Moving In Thursday's Pre-Market Session,2018-02-15 08:41:00-05:00,TTPH,neutral
1270381.0,42 Biggest Movers From Yesterday,2018-02-15 04:43:00-05:00,TTPH,neutral
1270382.0,Mid-Afternoon Market Update: Dow Jumps Over 200 Points; Fossil Group Shares Climb On Upbeat Earnings,2018-02-14 14:52:00-05:00,TTPH,positive
1270383.0,36 Stocks Moving In Wednesday's Mid-Day Session,2018-02-14 12:52:00-05:00,TTPH,neutral
1270384.0,Mid-Day Market Update: U.S. Stocks Turn Higher; Tetraphase Pharmaceuticals Shares Plummet,2018-02-14 12:37:00-05:00,TTPH,positive
1270385.0,"Tetraphase Pharmaceuticals Shares Down 59.5% Following Tuesday's Report Of Negative Trial Results For Eravacycline, And Subsequent Downgrade From BMO Wed. Morning",2018-02-14 12:08:00-05:00,TTPH,negative
1270386.0,Tetraphase Pharma Shares Plunge After Antibiotic Fails Late-Stage Trial,2018-02-14 11:55:00-05:00,TTPH,negative
1270387.0,Mid-Morning Market Update: Markets Mostly Lower; Groupon Profit Misses Views,2018-02-14 10:07:00-05:00,TTPH,negative
1270388.0,"Benzinga's Top Upgrades, Downgrades For February 14, 2018",2018-02-14 09:32:00-05:00,TTPH,positive
1270389.0,26 Stocks Moving In Wednesday's Pre-Market Session,2018-02-14 08:02:00-05:00,TTPH,neutral
1270390.0,BMO Capital Downgrades Tetraphase Pharmaceutical to Market Perform,2018-02-14 07:45:00-05:00,TTPH,neutral
1270391.0,Tetraphase Shares Down 57.5% After Hours Following Negative Trial Results For Eravacycline,2018-02-13 16:57:00-05:00,TTPH,negative
1270392.0,"UPDATE: Tetraphase Says 'Company Continues to Prepare for Commercialization of Eravacycline as a Treatment for cIAI in the U.S. and Europe, Assuming Regulatory Approval'",2018-02-13 16:03:00-05:00,TTPH,positive
1270393.0,Tetraphase Pharma Reports Top-Line Results From IGNITE3 Phase 3 Trial Of Eravacycline In cUTI Did Not Achieve Co-Primary Endpoints,2018-02-13 16:02:00-05:00,TTPH,neutral
1270394.0,"Benzinga's Top Upgrades, Downgrades For February 12, 2018",2018-02-12 09:33:00-05:00,TTPH,positive
1270395.0,"B. Riley Initiates Coverage On Tetraphase Pharmaceutical with Buy Rating, Announces $11.00 Price Target",2018-02-12 07:36:00-05:00,TTPH,neutral
1270396.0,Tetraphase Pharma S-3 Filing Shows Registration For $150M Mixed Securities Shelf Offering,2018-01-25 17:06:00-05:00,TTPH,positive
1270397.0,25 Stocks Moving In Wednesday's Pre-Market Session,2018-01-03 08:08:00-05:00,TTPH,neutral
1270398.0,A Peek Into The Markets: U.S. Stock Futures Rise Ahead Of Fed Minutes,2018-01-03 07:07:00-05:00,TTPH,neutral
1270399.0,"5 Stocks To Watch For January 3, 2018",2018-01-03 04:45:00-05:00,TTPH,neutral
1270400.0,6 Stocks Moving In Tuesday's After-Hours Session,2018-01-02 17:47:00-05:00,TTPH,neutral
1270401.0,Tetraphase Pharma Names Larry Tsai Chief Medical Officer,2018-01-02 16:35:00-05:00,TTPH,neutral
1270402.0,Tetraphase Submits NDA to FDA For Eravacycline,2018-01-02 16:31:00-05:00,TTPH,neutral
1270403.0,"Tetraphase Pharmaceuticals Reports Q3 EPS $(0.63) vs $(0.69) Est., Sales $4.06M",2017-11-02 08:05:00-04:00,TTPH,neutral
1270404.0,Tetraphawse Pharma Announces Kamalam Unninayar CFO,2017-10-16 09:12:00-04:00,TTPH,neutral
1270405.0,"Shares of Tetraphase Spiking Higher, Hearing BMO Raised Price Target From $13 to $24",2017-10-04 11:47:00-04:00,TTPH,positive
1270406.0,Tetraphase Pharma to Advance Oral Eravacycline into a Phase 2 Study in 1H 2018,2017-10-04 08:06:00-04:00,TTPH,neutral
1270407.0,"Tetraphase Pharma Complete Enrollment of IGNITE3 Phase 3 Trial, Expects Top Line Data in Q1 2018",2017-09-11 07:03:00-04:00,TTPH,positive
1270408.0,"Benzinga's Top Upgrades, Downgrades For August 28, 2017",2017-08-28 09:24:00-04:00,TTPH,positive
1270409.0,"PiperJaffray Initiates Coverage On Tetraphase Pharmaceutical with Overweight Rating, Announces $14.00 Price Target",2017-08-28 07:58:00-04:00,TTPH,negative
1270410.0,Tetraphase Pharmaceuticals Reports Submission and Validation of IV Eravacycline Marketing Authorization Application by European Medicines Agency,2017-08-17 08:30:00-04:00,TTPH,neutral
1270411.0,"Tetraphase Pharma Reports Q2 EPS $(0.83) vs $(0.74) Est., Sales $1.6M",2017-08-02 17:46:00-04:00,TTPH,neutral
1270412.0,Watch These 4 Huge Call Purchases In Monday Trade,2017-07-31 04:03:00-04:00,TTPH,positive
1270413.0,Benzinga's Option Alert Recap From July 28,2017-07-28 16:04:00-04:00,TTPH,positive
1270414.0,Tetraphase Option Alert: Nov 17 $7.5 Calls Sweep (2) at the Ask: 1000 @ $0.7 vs 913 OI; Ref=$6.4,2017-07-28 12:51:00-04:00,TTPH,positive
1270415.0,Tetraphase Prices 10M Share Offering @$6.50/Share,2017-07-28 04:32:00-04:00,TTPH,positive
1270416.0,Tetraphase Announces $60M Common Stock Offering,2017-07-26 16:35:00-04:00,TTPH,neutral
1270417.0,Mid-Afternoon Market Update: Crude Oil Up 1.8%; Triumph Group Shares Drop After Weak Earnings Report,2017-07-26 14:38:00-04:00,TTPH,negative
1270418.0,18 Biggest Mid-Day Gainers For Wednesday,2017-07-26 12:21:00-04:00,TTPH,neutral
1270419.0,Mid-Day Market Update: iRobot Surges On Strong Q2 Results; Wabash Shares Plunge,2017-07-26 12:04:00-04:00,TTPH,positive
1270420.0,Mid-Morning Market Update: Markets Open Higher; Ford Profit Beats Expectations,2017-07-26 10:13:00-04:00,TTPH,positive
1270421.0,"Benzinga's Top Upgrades, Downgrades For July 26, 2017",2017-07-26 09:25:00-04:00,TTPH,positive
1270422.0,"Tetraphase Pharmaceuticals Shares Up 25% Pre-Market Following Topline Phase 3 IGNITE4 Results Which Met The Primary Endpoint, Stifel Nicolaus Upgrade To Buy",2017-07-26 08:29:00-04:00,TTPH,positive
1270423.0,20 Stocks Moving In Wednesday's Pre-Market Session,2017-07-26 08:15:00-04:00,TTPH,neutral
1270424.0,Stifel Nicolaus Upgrades Tetraphase Pharmaceutical to Buy,2017-07-26 07:10:00-04:00,TTPH,neutral
1270426.0,"H.C. Wainwright Initiates Coverage On Tetraphase Pharmaceutical with Buy Rating, Announces $15.00 Price Target",2017-07-11 07:07:00-04:00,TTPH,neutral
1270427.0,"8-K From Tetraphase Pharma Shows Co., Patheon UK Entered Master Manufacturing Services Deal",2017-06-20 16:24:00-04:00,TTPH,neutral
1270428.0,Tetraphase Pharmaceuticals Announces 'Positive' Phase 1 Single-Ascending Dose Data for Antibiotic Pipeline Candidates,2017-06-05 08:01:00-04:00,TTPH,neutral
1270429.0,Watch These 7 Huge Put Purchases In Tuesday Trade,2017-05-16 04:15:00-04:00,TTPH,positive
1270430.0,Benzinga's Option Alert Recap From May 15,2017-05-15 16:16:00-04:00,TTPH,positive
1270431.0,Option Alert: Tetraphase Pharma Aug 5.0 Puts Sweep: 1306 @  ASK  $0.30: 1306 traded vs 109 OI:  Earnings 8/3 After Close [est]  $7.97 Ref,2017-05-15 14:43:00-04:00,TTPH,positive
1270432.0,"Tetraphase Pharmaceuticals Reports Q1 EPS $(0.79) vs $(0.59) Est., Sales $1.485M vs $1.46M Est.",2017-05-04 17:59:00-04:00,TTPH,neutral
1270433.0,Tetraphase Pharmaceuticals' TP-6076 Selected To Receive $4M in Research Funding,2017-03-30 16:02:00-04:00,TTPH,neutral
1270434.0,15 Biggest Mid-Day Gainers For Friday,2017-03-10 12:47:00-05:00,TTPH,neutral
1270435.0,Mid-Day Market Update: Finisar Drops After Disappointing Q3 Results; Internap Shares Surge,2017-03-10 12:08:00-05:00,TTPH,negative
1270436.0,Mid-Morning Market Update: Markets Open Higher; Genesco Profit Beats Views,2017-03-10 09:59:00-05:00,TTPH,positive
1270437.0,8 Biggest Price Target Changes For Friday,2017-03-10 09:58:00-05:00,TTPH,neutral
1270438.0,"Benzinga's Top Upgrades, Downgrades For March 10, 2017",2017-03-10 09:44:00-05:00,TTPH,positive
1270439.0,"BMO Capital Upgrades Tetraphase Pharmaceutical to Outperform, Raises Price Target to $10.00",2017-03-10 08:10:00-05:00,TTPH,neutral
1270440.0,"Tetraphase Pharmaceuticals Reports Q4 EPS $(0.61) vs. $(0.60) Est., Sales $1.09M vs. $1.37M Est.",2017-03-08 16:13:00-05:00,TTPH,neutral
1270441.0,Filing from Tetraphase Pharma Shows Registration for $40M Common Stock Offering,2017-01-17 16:45:00-05:00,TTPH,neutral
1270442.0,Tetraphase Pharma Reports Dosing of First Patient in IGNITE3 Phase 3 Trial of Once-Daily IV Eravacycline in cUTI,2017-01-17 08:03:00-05:00,TTPH,neutral
1270443.0,Tetraphase Pharmaceuticals To Submit MAA For Eravacycline For Treatment Of Complicated Intra-Abdominal Infections To EMA In 2H 2017,2016-12-19 08:03:00-05:00,TTPH,neutral
1270444.0,Tetraphase Shares Spike ~$0.20 Higher Over Last Min as Traders Circulating Unconfirmed Chatter from Questionable Source,2016-12-09 11:58:00-05:00,TTPH,negative
1270445.0,S-3 from Tetraphase Pharma Shows Registration for $100M Mixed Securities Shelf Offering,2016-11-08 16:35:00-05:00,TTPH,positive
1270446.0,"Tetraphase Pharma Reports Q3 EPS $(0.58) vs $(0.50) Est., Sales $900K vs $1.6M Est.",2016-11-03 16:53:00-04:00,TTPH,neutral
1270447.0,20 Stocks Which Rallied Three Days On Increasing Volume,2016-10-21 07:11:00-04:00,TTPH,neutral
1270448.0,"18 Stocks That Rallied For Three Days On Increasing Volume, No News",2016-10-21 06:37:00-04:00,TTPH,negative
1270449.0,Tetraphase Reports Dosing of First Patient in IGNITE4 Phase 3 Trial of Eravacycline in cIAI,2016-10-14 07:31:00-04:00,TTPH,neutral
1270450.0,7 Stocks Which Plummeted Three Days On Increasing Volume,2016-10-06 07:02:00-04:00,TTPH,neutral
1270451.0,"Tetraphase Reports Q2 Loss -$0.47 vs Est Loss/Share -$0.46,  Rev $1.2M",2016-08-04 16:56:00-04:00,TTPH,negative
1270452.0,Tetraphase Shows Antibiotics Pipeline Data at ASM 2016,2016-06-20 16:07:00-04:00,TTPH,neutral
1270453.0,Friday's 10 Biggest Mid-Day Losers,2016-05-13 12:29:00-04:00,TTPH,negative
1270454.0,Gabelli & Co Downgrades Tetraphase Pharmaceutical to Neutral,2016-05-13 08:47:00-04:00,TTPH,neutral
1270455.0,"Tetraphase Pharma Shares Resume, Now Down Nearly 18%; Co. Announced FDA Has Advised One Added Positive Phase 3 Trial Will Be Required to Support NDA Submission for IV Eravacycline",2016-05-12 16:40:00-04:00,TTPH,positive
1270456.0,"Tetraphase Pharma Reports Q1 EPS $(0.46) vs $(0.44) Est., Sales $2M vs $2.2M Est.",2016-05-04 16:31:00-04:00,TTPH,neutral
1270457.0,"BMO Capital Initiates Coverage on Tetraphase Pharmaceutical at Market Perform, Announces $8.00 PT",2016-04-12 06:01:00-04:00,TTPH,neutral
1270458.0,"Tetraphase Reports Q4 EPS $(0.50) vs $(0.44) Est., Sales $2.5M vs $3.23M Est.",2016-02-23 16:20:00-05:00,TTPH,neutral
1270459.0,Tetraphase Pharma Spikes to High of $4.91 on Volume,2016-02-09 13:17:00-05:00,TTPH,neutral
1270460.0,Tetraphase Pharmaceuticals Begins Phase 1 Clinical Trial for TP-271,2016-01-19 08:00:00-05:00,TTPH,neutral
1270461.0,Tetraphase Shares Falling,2016-01-11 10:00:00-05:00,TTPH,positive
1270462.0,13G Filing: Great Point Partners Reports 5.31% Stake In Tetraphase Pharmaceuticals,2015-12-24 09:23:00-05:00,TTPH,positive
1270463.0,Vetr Crowd Downgrades Tetraphase,2015-12-09 14:04:00-05:00,TTPH,neutral
1270464.0,Benzinga's Top Upgrades,2015-11-19 09:21:00-05:00,TTPH,positive
1270465.0,"SunTrust Robinson Humphrey Upgrades Tetraphase Pharmaceutical to Buy, Raises PT to $21.00",2015-11-19 06:35:00-05:00,TTPH,neutral
1270467.0,TetraPhase Presented Today at Stifel 2015 Healthcare Conference,2015-11-17 15:49:00-05:00,TTPH,neutral
1270468.0,TetraPhase Selling,2015-11-17 15:47:00-05:00,TTPH,neutral
1270469.0,Tetraphase Pharma Shares Falling,2015-11-17 15:47:00-05:00,TTPH,positive
1270470.0,"Tetraphase Pharma Reports Q3 Loss of $0.49/Share vs Loss of $0.65/Share Est., Sales $2.9M vs $3.2M Est.",2015-11-02 07:30:00-05:00,TTPH,negative
1270471.0,Leerink: Time To Buy Nabriva Therapeutics' 'Unique Differentiation',2015-10-13 08:49:00-04:00,TTPH,neutral
1270472.0,Eravacycline Data Supporting Activity Against Multidrug-Resistant Gram-Negative Bacteria to be Presented at IDWeek 2015,2015-10-07 08:06:00-04:00,TTPH,positive
1270473.0,Benzinga's Volume Movers,2015-09-15 10:30:00-04:00,TTPH,neutral
1270474.0,Biotechs Coming Off One Of The Busiest Weeks In Recent Memory,2015-09-14 13:44:00-04:00,TTPH,neutral
1270475.0,"Tetraphase's Stock Just Lost 80%, You Should Flush It...Right?",2015-09-09 14:22:00-04:00,TTPH,negative
1270476.0,Wall Street Analysts Abandon Tetraphase One Day Too Late,2015-09-09 13:15:00-04:00,TTPH,negative
1270477.0,"Goldman Sachs, Pepco, Walgreens Boots Alliance,  E*TRADE Lead Wednesday's Top Ratings Changes",2015-09-09 12:11:00-04:00,TTPH,positive
1270478.0,Stocks Hitting 52-Week Lows,2015-09-09 10:04:00-04:00,TTPH,negative
1270479.0,Mid-Morning Market Update: Markets Rise; HD Supply Profit Beats Views,2015-09-09 10:01:00-04:00,TTPH,positive
1270480.0,Morning Market Losers,2015-09-09 09:45:00-04:00,TTPH,negative
1270481.0,Benzinga's Top Downgrades,2015-09-09 09:16:00-04:00,TTPH,positive
1270482.0,Benzinga's Top #PreMarket Losers,2015-09-09 08:19:00-04:00,TTPH,negative
1270483.0,Tetraphase -78% Premarket Following Tuesday's Report that Top-Line Results from IGNITE2 Phase 3 Clinical Trial of Eravacycline in CUTI Did Not Meet Primary Endpoint,2015-09-09 07:56:00-04:00,TTPH,neutral
1270484.0,"JMP Analyst Estimate That Tetraphase Pharmaceuticals Has ~$200M In Cash and Cash Equivalents, Or $5/Share In Cash Which They View As A Bottom for The Stock",2015-09-09 07:47:00-04:00,TTPH,neutral
1270485.0,"Tuesday's After-Hours Movers Led By Akebia, Tetraphase, Pep Boys & TiVo",2015-09-09 06:55:00-04:00,TTPH,neutral
1270486.0,Brean Capital Downgrades Tetraphase Pharmaceutical to Hold,2015-09-09 05:42:00-04:00,TTPH,neutral
1270487.0,"Nomura Downgrades Tetraphase Pharmaceutical to Neutral, Lowers PT to $10.00",2015-09-09 04:59:00-04:00,TTPH,negative
1270488.0,Stifel Nicolaus Downgrades Tetraphase Pharmaceutical to Hold,2015-09-09 04:52:00-04:00,TTPH,neutral
1270489.0,JMP Securities Downgrades Tetraphase Pharmaceutical to Market Perform,2015-09-09 04:14:00-04:00,TTPH,positive
1270490.0,Biotech Hit After-Hours,2015-09-08 16:51:00-04:00,TTPH,neutral
1270491.0,"Tetraphase Falls Drastically After Hours, Trading Down From $44.78 To $9.26/Share; Down ~80% After Hours",2015-09-08 16:39:00-04:00,TTPH,neutral
1270492.0,Tetraphase To Resume Trading At 4:30pm ET,2015-09-08 16:18:00-04:00,TTPH,neutral
1270493.0,Tetraphase Reports Top-Line Results From IGNITE2 Phase 3 Clinical Trial of Eravacycline in cUTI; Did Not Achieve Primary Endpoint,2015-09-08 16:03:00-04:00,TTPH,neutral
1270494.0,Tetraphase Pharmaceuticals Halted,2015-09-08 16:01:00-04:00,TTPH,neutral
1270495.0,Tetraphase Reports FDA Grants QIDP Designation and Fast Track Status to TP-271,2015-09-03 08:02:00-04:00,TTPH,positive
1270496.0,"Tetraphase Pharma. Reports Q2 EPS $(0.72) vs. Est. $(0.62), Rev. $3.3M vs. Est. $2.73M",2015-08-05 16:41:00-04:00,TTPH,neutral
1270497.0,Tetraphase Names Jacques Dumas Chief Scientific Officer,2015-07-15 09:22:00-04:00,TTPH,neutral
1270498.0,SunTrust's 5 Biotech Picks For The Next 6 Months,2015-06-17 13:24:00-04:00,TTPH,neutral
1270499.0,"After-Hours Movers Wednesday: Whole Foods Market Inc., Keurig Green Mountain Inc.",2015-05-06 17:39:00-04:00,TTPH,neutral
1270500.0,This Tetraphase Pharma Analyst Expects Positive Data In Mid-2015,2015-04-28 07:14:00-04:00,TTPH,positive
1270501.0,Tetraphase Pharmaceuticals Reports Detailed Results From Phase 3 Trials of Eravacycline at 25th European Congress of Clinical Microbiology and Infectious Diseases,2015-04-27 07:01:00-04:00,TTPH,neutral
1270502.0,16 Biotech Catalysts SunTrust Is Tracking,2015-04-06 19:38:00-04:00,TTPH,neutral
1270503.0,SunTrust: Tetraphase Antibiotic Has 'Blockbuster Potential',2015-03-23 15:54:00-04:00,TTPH,positive
1270504.0,Benzinga's Top Initiations,2015-03-23 08:48:00-04:00,TTPH,positive
1270505.0,Nomura Initiates Tetraphase Pharmaceuticals With Buy,2015-03-23 08:46:00-04:00,TTPH,neutral
1270506.0,"SunTrust Robinson Humphrey Initiates Coverage on Tetraphase Pharmaceutical at Buy, Announces $48.00 PT",2015-03-23 06:19:00-04:00,TTPH,neutral
1270507.0,"Nomura Initiates Coverage on Tetraphase Pharmaceutical at Buy, Announces $54.00 PT",2015-03-23 06:19:00-04:00,TTPH,neutral
1270508.0,"Tetraphase Closes Public Offering, Report Gross Proceeds Of Approx. $173.1M",2015-03-17 12:28:00-04:00,TTPH,negative
1270509.0,FDA to Hold Superbug Scope Advisory Panel May 14-15,2015-03-12 09:38:00-04:00,TTPH,neutral
1270510.0,Tetraphase Pharma Prices Offering of 4.3M Shares at $35/Share,2015-03-11 18:28:00-04:00,TTPH,positive
1270511.0,Tetraphase Pharma Announces Offering Of 3.5M Shares,2015-03-09 16:50:00-04:00,TTPH,positive
1270512.0,S-3 from Tetraphase Shows Registration for Automatic Mixed Securities Shelf Offering,2015-03-09 16:21:00-04:00,TTPH,positive
1270513.0,Is Tetraphase Pharmaceuticals A Buyout Candidate? Brean Capital Thinks So,2015-03-06 10:46:00-05:00,TTPH,neutral
1270514.0,Tetraphase Pharmaceuticals Appoints Maria Stahl as Senior VP and General Counsel,2015-03-05 07:04:00-05:00,TTPH,neutral
1270515.0,JMP Securities Covers Mostly Good News From Pharma Pending More Visibility,2015-02-11 07:54:00-05:00,TTPH,positive
1270516.0,What Investors Should Be Watching In The Antibiotic Space,2014-12-31 15:44:00-05:00,TTPH,neutral
1270517.0,Former Goldman Sachs Executive On Problem That Can Cost The World $100 Trillion By 2050,2014-12-19 08:26:00-05:00,TTPH,negative
1270518.0,Tetraphase Shares Rise Amidst Positive Results Of A New 'Superbug' Fighting Drug,2014-12-18 13:11:00-05:00,TTPH,positive
1270519.0,"Brean Capital Maintains Buy on Tetraphase Pharmaceutical, Raises PT to $50.00",2014-12-18 06:52:00-05:00,TTPH,neutral
1270520.0,Tetraphase Announces Positive Top-line Results from Phase 3 IGNITE 1 Clinical Trial of Eravacycline,2014-12-17 16:01:00-05:00,TTPH,positive
1270521.0,Cellceutix Corp Shares Rise On Two Catalysts,2014-12-09 09:28:00-05:00,TTPH,positive
1270522.0,Mid-Afternoon Market Update: Trina Solar Drops After Quarterly Results; Tetraphase Pharmaceuticals Shares Spike Higher,2014-11-24 15:26:00-05:00,TTPH,positive
1270523.0,Mid-Day Market Update: Dow Edges Lower; Platinum Underwriters Shares Jump On Acquisition News,2014-11-24 13:55:00-05:00,TTPH,neutral
1270524.0,Mid-Morning Market Update: Markets Open Higher; BioMarin To Acquire Prosensa For $17.75/Share,2014-11-24 11:54:00-05:00,TTPH,neutral
1270525.0,"Mid-Day Gainers From November 24: Prosensa, Cimatron, Platinum Underwriters, Five Prime Therapeutics, Tetraphase Pharmaceuticals",2014-11-24 11:52:00-05:00,TTPH,neutral
1270526.0,Morning Market Movers,2014-11-24 09:46:00-05:00,TTPH,neutral
1270527.0,Benzinga's Top #PreMarket Gainers,2014-11-24 08:10:00-05:00,TTPH,positive
1270528.0,Tetraphase Pharma Reports Q3 EPS of $(0.55) vs $(0.56) Est; Revenue of $2.30M vs $2.86M Est,2014-11-10 16:38:00-05:00,TTPH,neutral
1270529.0,UPDATE: Wedbush Initiates Coverage On Tetraphase Pharmaceuticals On Room To Grow,2014-11-04 09:44:00-05:00,TTPH,neutral
1270530.0,"Wedbush Initiates Coverage on Tetraphase Pharma at Outperform, Announces $31.00 PT",2014-11-03 20:53:00-05:00,TTPH,neutral
1270531.0,Tetraphase Pharmaceuticals Announces Closing Of Public Offering of Common Stock,2014-10-22 16:12:00-04:00,TTPH,neutral
1270532.0,Benzinga's Volume Movers,2014-10-17 10:45:00-04:00,TTPH,neutral
1270533.0,Tetraphase Pharmaceuticals Prices 3.95M Share Offering @@$19.00/Share,2014-10-17 05:32:00-04:00,TTPH,positive
1270534.0,Markets Edge Higher; Netflix Shares Slip,2014-10-16 15:46:00-04:00,TTPH,positive
1270535.0,U.S. Stocks Fluctuate; Delta Air Shares Rise On Upbeat Earnings,2014-10-16 13:32:00-04:00,TTPH,positive
1270536.0,Markets Tumble; Goldman Sachs Posts Upbeat Earnings,2014-10-16 11:00:00-04:00,TTPH,neutral
1270537.0,Morning Market Losers ,2014-10-16 09:52:00-04:00,TTPH,negative
1270538.0,Tetraphase Pharmaceuticals Announces $75M Proposed Offering Of Common Stock,2014-10-15 16:11:00-04:00,TTPH,neutral
1270539.0,Tetraphase Pharmaceuticals to Present Data at IDWEEK on Activity of Eravacycline Against Multidrug-Resistant Bacteria ,2014-10-08 07:06:00-04:00,TTPH,neutral
1270540.0,Tetraphase Pharmaceuticals Announces Initiation of Pivotal Portion of IGNITE 2 Phase 3 Trial of Eravacycline in cUTI ,2014-10-06 16:07:00-04:00,TTPH,neutral
1270541.0,Tetraphase Pharma Shares Spike to High on Volume,2014-09-30 13:54:00-04:00,TTPH,positive
1270542.0,"Overbought And Oversold Stocks - Southwest Airlines Co, AFLAC Incorporated & More",2014-09-17 08:27:00-04:00,TTPH,neutral
1270543.0,"Cantor Initiates Coverage on Six Pharma Stocks, Each with Buy",2014-09-08 17:36:00-04:00,TTPH,neutral
1270544.0,Benzinga's Volume Movers,2014-09-03 10:27:00-04:00,TTPH,neutral
1270545.0,Morning Market Movers ,2014-09-03 09:43:00-04:00,TTPH,neutral
1270546.0,Tetraphase Announces Positive Oral Dosage data From Phase 3 Trials ,2014-09-02 16:04:00-04:00,TTPH,positive
1270547.0,Tetraphase Pharma Reports Q2 EPS of $(0.71) vs $(0.54) Est; Revenue of $1.30M vs $2.79M Est,2014-08-12 16:39:00-04:00,TTPH,neutral
1270548.0,Tetrapahse Pharma Announces Completion of IGNITE Phase 3 Enrollment,2014-07-28 08:02:00-04:00,TTPH,neutral
1270550.0,Tetraphase Completes Phase 3 Enrollment for Ignite,2014-06-19 08:05:00-04:00,TTPH,neutral
1270551.0,"Baird Initiates Coverage on Tetraphase Pharma at Outperform, Announces $21.00 PT",2014-06-16 16:50:00-04:00,TTPH,neutral
1270552.0,"WBB Securities Upgrades Tetraphase Pharma to Buy, Raises PT to $16.00",2014-06-02 10:59:00-04:00,TTPH,positive
1270553.0,Tetraphase Pharma Reports Q1 EPS of $(0.53) vs $(0.45) Est; Revenue of $2.46M vs $2.97M Est,2014-05-12 08:23:00-04:00,TTPH,neutral
1270554.0,Tetraphase Pharma Files $125M Securities Shelf,2014-05-01 16:53:00-04:00,TTPH,positive
1270555.0,Benzinga's Top Initiations,2014-04-04 07:33:00-04:00,TTPH,positive
1270556.0,"Brean Capital Initiates Coverage on Tetraphase Pharma at Buy, Announces $23.00 PT",2014-04-04 07:13:00-04:00,TTPH,neutral
1270557.0,Morning Market Movers,2014-04-02 09:40:00-04:00,TTPH,neutral
1270558.0,FDA Awards Fast Track Status to Tetraphase Pharmaceuticals for IV and Oral Formulations of Eravacycline,2014-04-02 08:34:00-04:00,TTPH,positive
1270559.0,UPDATE: Tetraphase Pharmaceuticals Provides Update on Clinical Progress of Phase 3 Lead Antibiotic Candidate Eravacycline,2014-03-20 13:13:00-04:00,TTPH,positive
1270560.0,"Tetraphase Pharma Offers Update on Clinical Progress of Phase 3 Lead Antibiotic Candidate Eravacycline, Says 50% of Patients Now Enrolled in IGNITE 1",2014-03-20 08:38:00-04:00,TTPH,positive
1270561.0,Tetraphase Pharma Reports Q4 EPS of $(0.49) vs $(0.46) Est; Revenue of $1.90M vs $2.10M Est,2014-03-06 07:06:00-05:00,TTPH,neutral
1270562.0,Tetraphase Pharma Reports Exercise of Underwriters' Option to Purchase Added Shares in Follow-On Offering,2013-11-19 16:03:00-05:00,TTPH,positive
1270563.0,Tetraphase Pharma Reports Q3 EPS of $(0.49) vs $(0.40) Est; Revenue of $2.20M vs $2.43M Est,2013-11-14 08:08:00-05:00,TTPH,neutral
1270564.0,"Guggenheim Securities Initiates Coverage on Tetraphase Pharma at Buy, Announces $25.00 PT",2013-11-13 08:26:00-05:00,TTPH,positive
1270565.0,Benzinga's Top #PreMarket Gainers,2013-11-13 08:19:00-05:00,TTPH,positive
1270566.0,Tetraphase Pharmaceuticals Announces Pricing of 4.5M Share Public Offering at $10 per Share,2013-11-07 09:11:00-05:00,TTPH,positive
1270567.0,Tetraphase Outlines Plans for Phase 3 Clinical Trial of Eravacycline IV/oral in Complicated Urinary Tract Infections ,2013-09-30 16:03:00-04:00,TTPH,neutral
1270568.0,"WBB Securities Initiates Coverage on Tetraphase Pharma at Speculative Buy, Announces $13.50 PT",2013-09-27 09:11:00-04:00,TTPH,positive
1270569.0,"Ladenburg Thalmann Initiates Coverage on Tetraphase Pharma at Buy, Announces $13.00 PT",2013-08-21 09:24:00-04:00,TTPH,neutral
1270570.0,Tetraphase Pharma Reports Q2 EPS of $(0.26) vs $(0.20) Est; Revenue of $3.70M vs $2.55M Est,2013-08-12 16:53:00-04:00,TTPH,neutral
1270571.0,Tetraphase Spikes Higher; May be Attributed to Positive Street.com Article,2013-08-07 10:38:00-04:00,TTPH,positive
1270572.0,"FDA Grants QIDP Designation to Eravacycline, Tetraphase's Lead Antibiotic Product Candidate ",2013-07-15 08:58:00-04:00,TTPH,positive
1270573.0,"Tetraphase Pharmaceuticals Added to Russell 3000®, Russell 2000® and Russell Global Indexes ",2013-07-01 07:12:00-04:00,TTPH,neutral
1270574.0,Tetraphase Pharma Reports Q1 EPS of $(0.30) vs $(0.27) Est,2013-05-13 16:30:00-04:00,TTPH,neutral
1270575.0,Tetraphase Issues Data Supporting Efficacy of Two Antiboitic Candidates at ECCMID,2013-04-29 08:48:00-04:00,TTPH,positive
1270576.0,"Stifel Nicolaus Initiates Coverage on Tetraphase Pharma at Buy, Announces $16.00 PT",2013-04-15 08:40:00-04:00,TTPH,neutral
1270577.0,"Stifel Nicolaus Initiates Coverage on Tetraphase Pharma at Buy, Announces $16.00 PT",2013-04-15 08:25:00-04:00,TTPH,neutral
1270578.0,"Needham Initiates Coverage on Tetraphase Pharma at Buy, Announces $12.00 PT",2013-04-15 07:57:00-04:00,TTPH,neutral
1270579.0,"BMO Capital Initiates Coverage on Tetraphase Pharma at Outperform, Announces $15.00 PT",2013-04-15 07:57:00-04:00,TTPH,neutral
1270580.0,"JMP Securities Initiates Coverage on Tetraphase Pharma at Market Outperform, Announces $12.00 PT",2013-04-15 07:57:00-04:00,TTPH,positive
1270581.0,"Barclays Initiates Coverage on Tetraphase Pharma at Overweight, Announces $16.00 PT",2013-04-15 07:56:00-04:00,TTPH,negative
1270582.0,"Tetraphase Pharma Says Underwriters for IPO Bought Added 797,792 Shares",2013-04-12 16:07:00-04:00,TTPH,positive
1270583.0,Tetraphase Pharma Shares Open for Trade Around $7.20,2013-03-20 10:00:00-04:00,TTPH,positive
1270584.0,"Tetraphase Pharma Shares to Open for Quote at 9:45AM EST, to Open for Trade at 10AM EST",2013-03-20 09:31:00-04:00,TTPH,positive
1270585.0,Tetraphase Pharma Prices IPO of 10.71M Shares at $7/Share,2013-03-20 08:30:00-04:00,TTPH,positive
1270586.0,"Tetraphase Raises Shares in IPO from 6.8M to 8.33M Shares, Lowers Price Range from $10-12 to $8-10/Share",2013-03-19 13:49:00-04:00,TTPH,positive
1270587.0,Tetraphase Pharma Expects to Price 6.8M Shares in $10-12/Share Range,2013-03-05 16:43:00-05:00,TTPH,positive
